Università LUM Giuseppe Degennaro - sito della Ricerca Institutional Research Information System

1.1 Articolo in rivista: [8557] Home page tipologia

Sfoglia
Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 3.441 a 3.460 di 8.557
Titolo Data di pubblicazione Autore(i) File
Physiologically based modelling of the antiplatelet effect of aspirin: A tool to characterize drug responsiveness and inform precision dosing 1-gen-2022 Alberto, Giaretta; Petrucci, Giovanna; Rocca, Bianca; Toffolo, Gm
The Aspirin Regimens in Essential Thrombocythemia (ARES) phase II randomized trial design - implementation of the serum thromboxane B2 assay as an evaluation tool of different aspirin dosing regimens in the clinical setting. (Rocca B and De Stefano V co-first Authors) 1-gen-2018 De Stefano, V; Rocca, B; Tosetto, A; Soldati, D; Petrucci, G; Beggiato, E; Bertozzi, I; Betti, S; Carli, G; Carpenedo, M; Cattaneo, D; Cavalca, V; Dragani, A; Elli, E; Finazzi, G; Iurlo, A; Lanzarone, G; Lissandrini, L; Palandri, F; Paoli, C; Rambaldi, A; Ranalli, P; Randi, Ml; Ricco, A; Rossi, E; Ruggeri, M; Specchia, G; Timillero, A; Turnu, L; Vianelli, N; Vannucchi, Am; Rodeghiero, F; Patrono, C.
Thromboxane biosynthesis and future events in diabetes: the ASCEND trial 1-gen-2024 Petrucci, G; Buck, Ga; Rocca, B; Parish, S; Baigent, C; Hatem, D; Mafham, M; Habib, A; Bowman, L; Armitage, J; Patrono, C
Heparin versus prostacyclin in continuous hemodiafiltration for acute renal failure: Effects on platelet function in the systemic circulation and across the filter 1-gen-2010 Arcangeli, A; Rocca, B; Salvatori, G; Ciancia, M; De Cristofaro, R; Antonelli, M
Effects of Unfractionated and Low Molecular Heparins on Thromboxane Biosynthesis "In Vivo" 1-gen-1994 Landolfi, R; De Candia, E; Rocca, B; Ciabattoni, G; Antinori, A; Masetti, R; Patrono, C
Symply read: erythrocytes modulate platelet function. should we rethink the way we give aspirin? 1-gen-1997 Rocca, B; Fitzgerald, Ga
Physiologically based modelling of the antiplatelet effect of aspirin: A tool to characterize drug responsiveness and inform precision dosing 1-gen-2022 Giaretta, A; Petrucci, G; Rocca, B; Toffolo, Gm.
Antithrombotic therapy and revascularisation strategies in people with diabetes and coronary artery disease 1-gen-2019 Rocca, B; Rubboli, A; Zaccardi, F.
Wiskott-Aldrich syndrome: report of an autosomal dominant variant 1-gen-1996 Rocca, B; Bellacosa, A; De Cristofaro, R; Della Ventura, M; Maggiano, N; Rumi, C and Landolfi R
Cardiovascular responses to the isoprostanes iPF(2alpha)-III and iPE(2)-III are mediated via the thromboxane A(2) receptor in vivo 1-gen-2000 Audoly, L; Rocca, B; Loeb, Al; Coffman TM and FitzGerald GA (Audoly L and Rocca, B equal Contributors)
Effect of fibrinogen concentration on the velocity of platelet aggregation 1-gen-1991 Landolfi, R; De Cristofaro, R; De Candia, E; Rocca, B; Bizzi, B
EHA Guidelines on Management of Antithrombotic Treatments in Thrombocytopenic Patients With Cancer 1-gen-2022 Falanga, A; Leader, A; Ambaglio, C; Bagoly, Z; Castaman, G; Elalamy, I; Lecumberri, R; Niessner, A; Pabinger, I; Szmit, S; Trinchero, A; Ten Cate, H; Rocca, B
A Genome-Wide Association Study of Diabetic Kidney Disease in Subjects With Type 2 Diabetes 1-gen-2018 van Zuydam, Nr; Ahlqvist, E; Sandholm, N; Deshmukh, H; Rayner, Nw; Abdalla, M; Ladenvall, C; Ziemek, D; Fauman, E; Robertson, Nr; Mckeigue, Pm; Valo, E; Forsblom, C; Harjutsalo, V; Finnish Diabetic Nephropathy Study, (FinnDiane); Perna, A; Rurali, E; Marcovecchio, Ml; Igo RP, Jr; Salem, Rm; Perico, N; Lajer, M; Käräjämäki, A; Imamura, M; Kubo, M; Takahashi, A; Sim, X; Liu, J; van Dam, Rm; Jiang, G; Tam, Cht; Luk, Aoy; Lee, Hm; Lim, Ckp; Szeto, Cc; So, Wy; Chan, Jcn; Hong Kong Diabetes Registry Theme-based Research Scheme Project, Group; Ang, Sf; Dorajoo, R; Wang, L; Clara, Tsh; Mcknight, Aj; Duffy, S; Warren, 3 and Genetics of Kidneys in Diabetes (GoKinD) Study Group; Pezzolesi, Mg; GENIE (GEnetics of Nephropathy an International Effort), Consortium; Marre, M; Gyorgy, B; Hadjadj, S; Hiraki, Lt; Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Interventions and Complications (EDIC) Research, Group; Ahluwalia, Ts; Almgren, P; Schulz, Ca; Orho-Melander, M; Linneberg, A; Christensen, C; Witte, Dr; Grarup, N; Brandslund, I; Melander, O; Paterson, Ad; Tregouet, D; Maxwell, Ap; Lim, Sc; Ma, Rcw; Tai, Es; Maeda, S; Lyssenko, V; Tuomi, T; Krolewski, As; Rich, Ss; Hirschhorn, Jn; Florez, Jc; Dunger, D; Pedersen, O; Hansen, T; Rossing, P; Remuzzi, G; SUrrogate markers for Micro- and Macrovascular hard endpoints for Innovative diabetes Tools (SUMMIT), Consortium; Rocca, B; Brosnan, Mj; Palmer, Cna; Groop, Ph; Colhoun, Hm; Groop, Lc; McCarthy MI., Rocca B part of the SUMMIT Consortium
Platelet mean volume, distribution width, and count in type 2 diabetes, impaired fasting glucose, and metabolic syndrome: a meta-analysis 1-gen-2015 Zaccardi, F; Rocca, B; Pitocco, D; Tanese, L; Rizzi, A; Ghirlanda, G
TNF-related apoptosis-inducing ligand (TRAIL) up-regulates cyclooxygenase (COX)-1 activity and PGE(2) production in cells of the myeloid lineage 1-gen-2002 Secchiero, P; Gonelli, A; Ciabattoni, G; Melloni, E; Grill, V; Rocca, B; Delbello, G; Zauli, G
Illustrated State-of-the-Art Capsules of the ISTH 2022 Congress 1-gen-2022 Ariëns, R. A.; Hunt, B. J.; Agbani, E. O.; Rocca, B; Zafar, T.; Zhou, J.
Autosomal-dominant giant platelet syndromes: a hint of the same genetic defect as in Fechtner syndrome owing to a similar genetic linkage to chromosome 22q11-13 1-gen-2000 Toren, A; Rozenfeld-Granot, G; Rocca, B; Epstein, Cj; Amariglio, N; Laghi, F; Landolfi, R; Brok-Simoni, F; Carlsson, Le; Rechavi, G; Greinacher, A
MYH9 spectrum of autosomal-dominant giant platelet syndromes: Unexpected association with fibulin-1 variant-D inactivation 1-gen-2003 Toren, A; Rozenfeld-Granot, G; Heath, Ke; Amariglio, N; Rocca, B; Crosson, J; Epstein, Cj; Laghi, F; Landolfi, R; Carlsson, Le; Argraves, S; Bizzaro, N; Moxey-Mims, M; Brok-Simoni, F; Martignetti, Ja; Greinacher, A; Rechavi, G
Evidence for a founder effect of the MPL-S505N mutation in eight Italian pedigrees with hereditary thrombocythemia 1-gen-2009 Liu, K; Martini, M; Rocca, B; Amos, Ci; Teofili, L; Giona, F; Ding, J; Komatsu, H; Larocca, Lm; Skoda, Rc
Very-low-dose twice-daily aspirin maintains platelet inhibition and improves haemostasis during dual-antiplatelet therapy for acute coronary syndrome 1-gen-2019 Parker, William A. E.; Orme, Rachel C.; Hanson, Jessica; Stokes, Hannah M.; Bridge, Claire M.; Shaw, Patricia A.; Sumaya, Wael; Thorneycroft, Kirstie; Petrucci, Giovanna; Porro, Benedetta; Judge, Heather M.; Ajjan, Ramzi A.; Rocca, Bianca; Storey, Robert F.
Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 3.441 a 3.460 di 8.557
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile

Scopri
Tipologia
  • 1 Contributo su Rivista8556
Autore
  • IACOVIELLO, LICIA751
  • CASTELLANI, DANIELE303
  • CORMIO, LUIGI239
  • PICCA, ANNA233
  • MEMEO, RICCARDO226
  • ROCCA, BIANCA224
  • MAGAZZINO, COSIMO221
  • BELLOMO, ROSA210
  • FIORENTINO, ALBA202
  • TROIANO, GIUSEPPE196
Data di pubblicazione
  • In corso di stampa28
  • 2020 - 20263930
  • 2010 - 20193195
  • 2000 - 20091043
  • 1990 - 1999298
  • 1980 - 198961
  • 1977 - 19791
Rivista
  • INTERNATIONAL JOURNAL OF MOLECULA...101
  • PLOS ONE76
  • CANCERS62
  • NUTRIENTS62
  • JOURNAL OF CLINICAL MEDICINE61
  • NMCD. NUTRITION METABOLISM AND CA...54
  • SCIENTIFIC REPORTS52
  • THROMBOSIS AND HAEMOSTASIS52
  • INTENSIVE CARE MEDICINE50
  • WORLD JOURNAL OF UROLOGY37
Keyword
  • Humans240
  • COVID-19113
  • Male98
  • Female94
  • Italy85
  • Aged67
  • Middle Aged62
  • Adult55
  • inflammation49
  • SARS-CoV-246
Lingua
  • eng5281
  • ita875
  • fre12
  • spa11
  • ger3
  • und2
  • afr1
  • bul1
  • lat1
Accesso al fulltext
  • no fulltext8556